FLGT (Fulgent Genetics) Accounts Payable: $21.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FLGT Fulgent Genetics Inc FLGT
64 GF Score
Price $20.71
GF Value $24.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fulgent Genetics Accounts Payable?

Fulgent Genetics FLGT +1.22% 64 Accounts Payable is $21.1 Mil as of Mar. 2026. GuruFocus rates FLGT with a GF Score™ of 64/100 and a GF Value™ of $24.14 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Fulgent Genetics's Accounts Payable for the quarter that ended in Mar. 2026 was $21.1 Mil.

Fulgent Genetics's quarterly Accounts Payable increased from Sep. 2025 ($18.1 Mil) to Dec. 2025 ($18.7 Mil) and increased from Dec. 2025 ($18.7 Mil) to Mar. 2026 ($21.1 Mil).

Fulgent Genetics's annual Accounts Payable increased from Dec. 2023 ($15.4 Mil) to Dec. 2024 ($18.4 Mil) and increased from Dec. 2024 ($18.4 Mil) to Dec. 2025 ($18.7 Mil).

Fulgent Genetics Accounts Payable Related Terms

Fulgent Genetics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics Accounts Payable Chart

Fulgent Genetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.49 23.09 15.36 18.36 18.65

Fulgent Genetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.24 18.89 18.09 18.65 21.13
FLGT
64GF Score
Fulgent Genetics Inc FLGT
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $21.1 Mil mean?
Fulgent Genetics (FLGT) has a Accounts Payable of $21.1 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Fulgent Genetics and its competitors.
Is Fulgent Genetics' Accounts Payable too high?
Fulgent Genetics' current Accounts Payable is $21.1 Mil. Overall, Fulgent Genetics has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Accounts Payable compare to MYGN and CSTL?
Fulgent Genetics' Accounts Payable of $21.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Fulgent Genetics and its competitors. Fulgent Genetics's current Accounts Payable is $21.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (FLGT) is currently considered Modestly Undervalued. The stock's GF Value™ is $24.14, compared to a current price of $20.71 — trading 14.2% below its estimated fair value. The current Accounts Payable is $21.1 Mil. Fulgent Genetics' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Fulgent Genetics (FLGT), the current Accounts Payable is $21.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of $20.71 is trading 14.2% below its estimated GF Value™ of $24.14. GuruFocus considers Fulgent Genetics to be Modestly Undervalued.

Key valuation signals for FLGT:

  • Accounts Payable: $21.1 Mil
  • GF Value™: $24.14 vs. price of $20.71 (14.2% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fulgent Genetics Business Description

Other Exchanges FLGT:Mexico
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
64GF Score

Get the complete analysis for FLGT

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.71
Price
$24.14
GF Value